2022
DOI: 10.1016/j.jad.2022.04.058
|View full text |Cite
|
Sign up to set email alerts
|

Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
10
0
1

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 54 publications
0
10
0
1
Order By: Relevance
“…Selenium supplementation in rodents is beneficial for treating depression. The salt form of selenium, sodium selenite, had antidepressant effects in rodents [ 142 ]. Sodium selenite can increase the antidepressant effect of imipramine, fluoxetine, and tianeptine and reduce immobility time on the forced swim test (FST) after the administration of antidepressants [ 143 ].…”
Section: Appropriate Supplementation Of Some Mineral Elements or As M...mentioning
confidence: 99%
“…Selenium supplementation in rodents is beneficial for treating depression. The salt form of selenium, sodium selenite, had antidepressant effects in rodents [ 142 ]. Sodium selenite can increase the antidepressant effect of imipramine, fluoxetine, and tianeptine and reduce immobility time on the forced swim test (FST) after the administration of antidepressants [ 143 ].…”
Section: Appropriate Supplementation Of Some Mineral Elements or As M...mentioning
confidence: 99%
“…Lithium is a metal with a long-lasting history of use as first-line drug for treating bipolar disorder, as well as recurrent depression [ 86 ]. Lithium-induced pharmacological effects were explained by replenishment with BDNF and NGF in patients with depression.…”
Section: Current Insight Into the Potential Of Regenerative Medicine ...mentioning
confidence: 99%
“…One older meta-analysis of pharmacological interventions in bipolar disorder states that there were no robust data available to assess the effectiveness of lithium in treating bipolar depression (Selle et al, 2014). Two recent systematic reviews and meta-analysis reached the same conclusion (Fountoulakis et al, 2022;Rakofsky et al, 2022). At the same time, several guidelines like those from the "Canadian Network for Mood and Anxiety Treatments" (CANMAT) and the "International Society for Bipolar Disorders" (ISBD) (Yatham et al, 2018) advise treatment of bipolar depression with lithium and recommend a target serum concentration of 0.8-1.2 mmol/L.…”
Section: Introductionmentioning
confidence: 98%